A scientific statement has been published by the AHA and ACC regarding using risk assessment for BP management for prevention of CVD.

Discover Alector's latest breakthroughs in neurodegenerative disease therapies, including updates on Alzheimer's and Parkinson's programs.

Objective Youth with childhood-onset SLE (cSLE) have increased risk of serious infection. It is unknown how much of this risk ...

Standardizing measurement methods and outcomes may improve clinical trial reproducibility in myopia management.

MADRID, Aug. 31, 2025 /PRNewswire/ --Johnson & Johnson (NYSE: JNJ) – Late breaking clinical science data, presented at the European Society of Cardiology (ESC) Congress today and simultaneously ...

Johnson & Johnson reports late breaking clinical science data, presented at the European Society of Cardiology Congress and simultaneously published in the New England Journal of Medicine, finds at up ...

The Study Design and Data Analysis support group at USF’s College of Public Health (COPH), that’s who. Known as the SDDA, the ...

Peer reviewers judge the validity and quality of new research. These judgements would ideally be impartial, but some reviewers may give a more favourable review if they are cited in the article ...

Introduction Patients with arthralgia at-risk for rheumatoid arthritis (RA) experience considerable functional disability, though generally less than at RA diagnosis. Secondary prevention trials have ...

Novo Nordisk today presented data from the STEER real-world study of evidence gathered from actual patient experiences at the European Society of Cardiology (ESC) Congress 2025 in Madrid, Spain. The ...